<?xml version="1.0" encoding="UTF-8"?>
<p>The primary outcome measure of this trial is the incidence of perioperative hypotensive events, defined as MBP &lt;65 mmHg or â‰¥30% reduction in MBP from baseline for which an intervention is needed (including intravenous fluids infusion and/or use of vasopressors), which occur during surgery and in the PACU.</p>
